Abel Hall, LLC Enochian Biosciences Inc Transaction History
Abel Hall, LLC
- $166 Billion
- Q1 2025
A detailed history of Abel Hall, LLC transactions in Enochian Biosciences Inc stock. As of the latest transaction made, Abel Hall, LLC holds 17,165 shares of ENOB stock, worth $78,959. This represents 0.01% of its overall portfolio holdings.
Number of Shares
17,165
Previous 12,420
38.2%
Holding current value
$78,959
Previous $10.4 Million
10.15%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding ENOB
# of Institutions
65Shares Held
18.1MCall Options Held
101KPut Options Held
23.3K-
Vanguard Group Inc Valley Forge, PA5.66MShares$26 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.66MShares$16.8 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.37MShares$10.9 Million0.0% of portfolio
-
State Street Corp Boston, MA2MShares$9.21 Million0.0% of portfolio
-
Northern Trust Corp Chicago, IL832KShares$3.83 Million0.0% of portfolio
About Enochian Biosciences Inc
- Ticker ENOB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,950,000
- Market Cap $244M
- Description
- Enochian Biosciences, Inc., a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), influenza and coronavirus infections, and cancer. The company's lead candidate includes ENOB-HV-01 for au...